14.74
price up icon1.31%   0.19
after-market 시간 외 거래: 14.60 -0.14 -0.95%
loading
전일 마감가:
$14.55
열려 있는:
$14.745
하루 거래량:
1.92M
Relative Volume:
0.84
시가총액:
$46.90B
수익:
$30.08B
순이익/손실:
$710.16M
주가수익비율:
67.55
EPS:
0.2182
순현금흐름:
$4.45B
1주 성능:
+0.14%
1개월 성능:
+0.14%
6개월 성능:
+14.09%
1년 성능:
+7.91%
1일 변동 폭
Value
$14.73
$14.78
1주일 범위
Value
$14.41
$14.79
52주 변동 폭
Value
$12.80
$15.53

다케다약품공업 ADR Stock (TAK) Company Profile

Name
명칭
Takeda Pharmaceutical Co Adr
Name
전화
-
Name
주소
-
Name
직원
47,455
Name
트위터
@takedapharma
Name
다음 수익 날짜
2024-10-31
Name
최신 SEC 제출 서류
Name
TAK's Discussions on Twitter

TAK을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.74 45.95B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
153.45 67.31B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.75 43.35B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.58 18.68B 16.54B -1.64B 749.00M -1.45
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
305.61 13.44B 2.99B 1.21B 1.13B 25.06

다케다약품공업 ADR Stock (TAK) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-04-02 업그레이드 Morgan Stanley Equal-Weight → Overweight
2023-03-16 업그레이드 BofA Securities Neutral → Buy
2022-07-19 업그레이드 Cowen Market Perform → Outperform
2021-10-07 다운그레이드 Morgan Stanley Overweight → Equal-Weight
2021-04-19 다운그레이드 JP Morgan Overweight → Neutral
2019-11-01 개시 Cowen Market Perform
2019-08-15 다운그레이드 Daiwa Securities Outperform → Neutral
모두보기

다케다약품공업 ADR 주식(TAK)의 최신 뉴스

pulisher
Jul 21, 2025

Why This Biotech's Dive Benefits Its Top Three Rivals - Investor's Business Daily

Jul 21, 2025
pulisher
Jul 17, 2025

Takeda: Positioned To Tackle Future Clinical Demand In A Highly Regulated Sector (TAK) - Seeking Alpha

Jul 17, 2025
pulisher
Jul 17, 2025

Behind Takeda Pharmaceutical Co ADR’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com

Jul 17, 2025
pulisher
Jul 15, 2025

Takeda stock rises after positive Phase 3 results for narcolepsy drug - Investing.com

Jul 15, 2025
pulisher
Jul 14, 2025

Takeda stock rises after positive Phase 3 results for narcolepsy drug By Investing.com - Investing.com South Africa

Jul 14, 2025
pulisher
Jul 12, 2025

Haleon PLC Sponsored ADR (NYSE:HLN) Shares Purchased by Allspring Global Investments Holdings LLC - Defense World

Jul 12, 2025
pulisher
Jul 11, 2025

Functional Dyspepsia Market Analysis and Forecast, 2025-2035, Competitive Analysis of AstraZeneca, P&G, Takeda, Prestige Consumer Healthcare, Kenvue Brands, Dr. Reddy's, Pfizer, ZERIA, Daewoong - GlobeNewswire Inc.

Jul 11, 2025
pulisher
Jul 10, 2025

Takeda Pharmaceutical ADR Earns RS Rating Upgrade - MSN

Jul 10, 2025
pulisher
Jul 07, 2025

Nomura Holdings Inc ADR (NYSE:NMR) Shares Acquired by GAMMA Investing LLC - Defense World

Jul 07, 2025
pulisher
Jul 03, 2025

Hengan International Group (OTCMKTS:HEGIY) Stock Price Up 3.7% – Time to Buy? - Defense World

Jul 03, 2025
pulisher
Jul 02, 2025

Expedia Group Earns RS Rating Upgrade - inkl

Jul 02, 2025
pulisher
Jul 01, 2025

BioNTech ADR Earns Relative Strength Rating Upgrade - inkl

Jul 01, 2025
pulisher
Jun 30, 2025

GAMMAGARD LIQUID ERC, GAMMAGARD LIQUID and GAMMAGARD S/D U.S. Important Safety Information - Placera.se

Jun 30, 2025
pulisher
Jun 26, 2025

Stocks With Rising Relative Price Strength: IREN - inkl

Jun 26, 2025
pulisher
Jun 25, 2025

Stocks With Rising Relative Strength: Takeda Pharmaceutical ADR - inkl

Jun 25, 2025
pulisher
Jun 12, 2025

Nano Dimension Ltd ADR’s Shares Reel: -28.07% Quarterly Revenue Decline Amid 329.06M Market Cap - investchronicle.com

Jun 12, 2025
pulisher
Jun 12, 2025

MNST’s Stock Market Adventure: 19.08% YTD Growth Amidst Volatility - investchronicle.com

Jun 12, 2025
pulisher
Jun 09, 2025

SEC Form N-CSRS filed by abrdn World Healthcare Fund Shares of Beneficial Interest - Quantisnow

Jun 09, 2025
pulisher
Jun 02, 2025

IgA nephropathy Pipeline Drugs Analysis 2025: Clinical Trials, - openPR.com

Jun 02, 2025
pulisher
May 30, 2025

CTVA’s Stock Market Adventure: 22.38% YTD Growth Amidst Volatility - investchronicle.com

May 30, 2025
pulisher
May 28, 2025

Takeda files executive compensation report with SEC - Investing.com

May 28, 2025
pulisher
May 22, 2025

Cameco Earns Relative Strength Rating Upgrade; Hits Key Threshold - inkl

May 22, 2025
pulisher
May 21, 2025

TD Cowen maintains Buy on Takeda, reiterates $16 target By Investing.com - Investing.com India

May 21, 2025
pulisher
May 20, 2025

Stocks With Rising Relative Strength: Novartis ADR - inkl

May 20, 2025
pulisher
May 19, 2025

Fidelity Natl Info Svcs Shows Rising Relative Strength; Still Shy Of Key Benchmark - inkl

May 19, 2025
pulisher
May 15, 2025

Real-World Effectiveness and Safety of Vedolizumab in Patients ≥ 70 Versus - Wiley Online Library

May 15, 2025
pulisher
May 12, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

May 12, 2025
pulisher
May 09, 2025

Financial Metrics Unveiled: Topgolf Callaway Brands Corp (MODG)’s Key Ratios in the Spotlight - DWinneX

May 09, 2025
pulisher
May 09, 2025

Ratios Reveal: Breaking Down Takeda Pharmaceutical Co ADR (TAK)’s Financial Health - DWinneX

May 09, 2025
pulisher
May 09, 2025

Balance Sheet Insights: Nuveen Churchill Direct Lending Corp (NCDL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - DWinneX

May 09, 2025
pulisher
May 08, 2025

Takeda continues stock plan for management in 2025 - Investing.com

May 08, 2025
pulisher
May 02, 2025

TAK or DSNKY: Which Is the Better Value Stock Right Now? - Yahoo Finance

May 02, 2025
pulisher
May 01, 2025

Taking a look at what insiders are doing to gauge the Takeda Pharmaceutical Co ADR (TAK)’s direction - knoxdaily.com

May 01, 2025
pulisher
Apr 28, 2025

Takeda Pharmaceutical Co ADR [TAK] Insider Activity: An Update for Investors - knoxdaily.com

Apr 28, 2025
pulisher
Apr 25, 2025

Exelixis' Q1 Earnings: Will Cabometyx Maintain Momentum? - Yahoo Finance

Apr 25, 2025
pulisher
Apr 25, 2025

A significant driver of top-line growth: Takeda Pharmaceutical Co ADR (TAK) - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Nothing is Better Than C.H. Robinson Worldwide, Inc (CHRW) stock at the moment - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Takeda Pharmaceutical Co ADR Inc. (TAK) Price Performance: A Comparative Analysis with Competitors - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Carmax Inc: Analyzing KMX Stock Trends - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

Klaviyo Inc (KVYO) Stock: The Story of a 52-Week Stock Range - investchronicle.com

Apr 25, 2025
pulisher
Apr 25, 2025

You might want to take a look at Denison Mines Corp (DNN) now - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

A Look at Cousins Properties Inc (CUZ) Shares in the Recent Past Indicates Growth - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

A better buy-in window may exist right now for Cheesecake Factory Inc (CAKE) - Sete News

Apr 25, 2025
pulisher
Apr 25, 2025

Stocks of CN Energy Group Inc (CNEY) are poised to climb above their peers - Sete News

Apr 25, 2025
pulisher
Apr 22, 2025

Analyzing Takeda Pharmaceutical Co ADR (TAK) After Recent Trading Activity - knoxdaily.com

Apr 22, 2025
pulisher
Apr 22, 2025

Cintas Corporation [CTAS] Insider Activity: An Update for Investors - knoxdaily.com

Apr 22, 2025
pulisher
Apr 16, 2025

TAK vs. DSNKY: Which Stock Is the Better Value Option? - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

Organon expands board with new director from Takeda - Investing.com

Apr 15, 2025
pulisher
Apr 09, 2025

Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading - MSN

Apr 09, 2025
pulisher
Apr 03, 2025

Asian ADRs Take A Hit As S&P Asia 50 Dips - Finimize

Apr 03, 2025
pulisher
Apr 02, 2025

Morgan Stanley lifts Takeda stock rating, raises target to JPY5,500 - Investing.com

Apr 02, 2025

다케다약품공업 ADR (TAK) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
drug_manufacturers_specialty_generic HLN
$9.75
price up icon 1.04%
drug_manufacturers_specialty_generic ZTS
$153.45
price up icon 1.49%
$16.58
price up icon 1.78%
$305.61
price up icon 2.59%
$133.66
price up icon 0.69%
자본화:     |  볼륨(24시간):